Company Filing History:
Years Active: 2002
Title: Angela Lombardo-Bencheikh: Innovator in Papillomavirus Vaccine Development
Introduction
Angela Lombardo-Bencheikh is a notable inventor based in Wavre, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. Her work focuses on addressing health challenges posed by human papillomavirus (HPV).
Latest Patents
Angela holds a patent for a recombinant papillomavirus vaccine and method for production and treatment. This invention relates to fusion proteins that comprise a protein or part of a protein providing T helper epitopes and an antigen from a human-papilloma virus. Specifically, the invention includes fusion proteins comprising an E6 or E7 protein from HPV strains 16 or 18 linked to protein D from B. The vaccine compositions developed through this invention are useful in the treatment or prophylaxis of human papilloma-induced tumors. Angela has 1 patent to her name.
Career Highlights
Angela Lombardo-Bencheikh is associated with SmithKline Beecham Biologicals S.A., where she has contributed to groundbreaking research in vaccine development. Her innovative approach has positioned her as a key figure in the fight against HPV-related diseases.
Collaborations
Angela has collaborated with esteemed colleagues, including Claudine Bruck and Teresa Cabezon Silva. These partnerships have enhanced her research efforts and contributed to the advancement of vaccine technology.
Conclusion
Angela Lombardo-Bencheikh's work in the development of a recombinant papillomavirus vaccine showcases her dedication to improving public health. Her innovative contributions are vital in the ongoing battle against HPV-related health issues.